Vivos RDGL
OTC RDGL
$0.06 0.00 (-1.13%)
At close: Aug 19, 2026 · 3:54 PM UTC

Vivos (RDGL) Receivables - Other (2010 - 2017)

Vivos (RDGL) posted Receivables - Other of $137000.0 for Q4 2017, little changed sequentially from $137000.0 in Q3 2017, and up 7.42% YoY from $127533.0 in Q4 2016.

Vivos (RDGL) Receivables - Other (2010 - 2017) Analysis & Trends

Vivos has reported Receivables - Other for 4 years, with the latest figure at $137000.0 in Q4 2017.

  • Quarterly Receivables - Other rose 7.42% year-over-year to $137000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $137000.0 (up 7.42% YoY) and the FY2017 annual result came in at $137000.0, up 7.42% from the prior year.
  • Receivables - Other steadied at $137000.0 in Q4 2017 per RDGL's latest filing, from $137000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $137000.0 in Q1 2017 and troughed at $127533.0 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn
2 Stryker 129.95 Bn 126.47 Bn 4.50 Bn
3 Medtronic 120.06 Bn 110.84 Bn 6.41 Bn
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 52.74 Bn 48.49 Bn 1.35 Bn
6 Dexcom 34.60 Bn 32.65 Bn 830.00 Mn
7 GE HealthCare Technologies 34.20 Bn 32.10 Bn 2.18 Bn
8 Koninklijke Philips 26.46 Bn 23.13 Bn 4.55 Bn
9 Steris 23.25 Bn 22.77 Bn 684.20 Mn
10 Vivos 24.90 Mn 23.34 Mn -3,105.00

Historic Data

Download Data
DateValue
Dec 31, 2017 137,000.00
Dec 31, 2017 137,000.00
Sep 30, 2017 137,000.00
Sep 30, 2017 137,000.00
Jun 30, 2017 137,000.00
Jun 30, 2017 137,000.00
Mar 31, 2017 137,000.00
Mar 31, 2017 137,000.00
Dec 31, 2016 127,533.00
Dec 31, 2016 127,533.00
Dec 31, 2011 25,000.00
Dec 31, 2011 25,000.00
Jun 30, 2011 125,000.00
Jun 30, 2011 125,000.00
Mar 31, 2011 300,504.00
Mar 31, 2011 300,504.00
Dec 31, 2010 -41,675.00
Dec 31, 2010 -41,675.00